ADIM
LRN icon

Alpha DNA Investment Management’s Stride LRN Stock Holding History

Alpha DNA Investment Management’s Portfolio LRN Stock Details LRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,486
Closed -$1.04M – 198
2023
Q1 		$1.04M Buy
+26,486
New +$1.04M 0.31% 106

Other funds holding LRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha DNA Investment Management's LRN Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Stride (LRN) in Q2 2023, closing a stake of 26,486 shares — an estimated $1.04M sold.

Alpha DNA Investment Management first reported a position in LRN in Q1 2023 and held it in 1 quarter. The position peaked at $1.04M in Q1 2023. 237 funds tracked by Wall St. Rank hold LRN as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Stride position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 26,486 Stride shares in Q2 2023, an estimated $1.04M.
  • Alpha DNA Investment Management first reported a position in Stride in Q1 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's Stride position peaked at $1.04M in Q1 2023.
  • 237 funds tracked by Wall St. Rank held Stride as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.